Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Aronson

Showing results (291-300 of 572) with videos related to

Pageof 58
Sort By:
Urology|April 21, 2007
Optimal timing, cutoff, and method of calculation of preoperative prostate-specific antigen velocity to predict relapse after prostatectomy: a report from SEARCHChristopher R King, Stephen J Freedland, Martha K Terris, et al.
The Journal of Urology|March 18, 2008
Limitations of prostate specific antigen doubling time following biochemical recurrence after radical prostatectomy: results from the SEARCH databaseRobert J Hamilton, William J Aronson, Martha K Terris, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 26, 2016
Inherited Chromosomally Integrated Human Herpesvirus 6 and Breast CancerAnnie Gravel, Isabelle Dubuc, Angela Brooks-Wilson, et al.
BMJ Open|March 12, 2015
Cervical cancer screening and HPV vaccine acceptability among rural and urban women in Kilimanjaro Region, TanzaniaMelissa S Cunningham, Emily Skrastins, Ryan Fitzpatrick, et al.
Cancer Causes & Control : CCC|September 8, 2001
Organochlorines and breast cancer risk by receptor status, tumor size, and grade (Canada)C G Woolcott, K J Aronson, W M Hanna, et al.
Cancer|March 21, 2014
The impact of pathologic staging on the long-term oncologic outcomes of patients with clinically high-risk prostate cancerMichael R Abern, Martha K Terris, William J Aronson, et al.
Cancer|September 19, 2007
Race, biochemical disease recurrence, and prostate-specific antigen doubling time after radical prostatectomy: results from the SEARCH databaseRobert J Hamilton, William J Aronson, Joseph C Presti, et al.
Prostate Cancer and Prostatic Diseases|July 16, 2008
Impact of nerve sparing on surgical margins and biochemical recurrence: results from the SEARCH databaseJ L Nelles, S J Freedland, J C Presti, et al.
The Journal of Urology|August 19, 2007
Predicting unilateral prostate cancer based on biopsy features: implications for focal ablative therapy--results from the SEARCH databaseCharles D Scales, Joseph C Presti, Christopher J Kane, et al.
BJU International|November 22, 2008
Do nomograms predict aggressive recurrence after radical prostatectomy more accurately than biochemical recurrence alone?Florian R Schroeck, William J Aronson, Joseph C Presti, et al.
Pageof 58

Showing results (291-300 of 572) with videos related to

Sort By:
Pageof 58
Urology|April 21, 2007
Optimal timing, cutoff, and method of calculation of preoperative prostate-specific antigen velocity to predict relapse after prostatectomy: a report from SEARCHChristopher R King, Stephen J Freedland, Martha K Terris, et al.
The Journal of Urology|March 18, 2008
Limitations of prostate specific antigen doubling time following biochemical recurrence after radical prostatectomy: results from the SEARCH databaseRobert J Hamilton, William J Aronson, Martha K Terris, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 26, 2016
Inherited Chromosomally Integrated Human Herpesvirus 6 and Breast CancerAnnie Gravel, Isabelle Dubuc, Angela Brooks-Wilson, et al.
BMJ Open|March 12, 2015
Cervical cancer screening and HPV vaccine acceptability among rural and urban women in Kilimanjaro Region, TanzaniaMelissa S Cunningham, Emily Skrastins, Ryan Fitzpatrick, et al.
Cancer Causes & Control : CCC|September 8, 2001
Organochlorines and breast cancer risk by receptor status, tumor size, and grade (Canada)C G Woolcott, K J Aronson, W M Hanna, et al.
Cancer|March 21, 2014
The impact of pathologic staging on the long-term oncologic outcomes of patients with clinically high-risk prostate cancerMichael R Abern, Martha K Terris, William J Aronson, et al.
Cancer|September 19, 2007
Race, biochemical disease recurrence, and prostate-specific antigen doubling time after radical prostatectomy: results from the SEARCH databaseRobert J Hamilton, William J Aronson, Joseph C Presti, et al.
Prostate Cancer and Prostatic Diseases|July 16, 2008
Impact of nerve sparing on surgical margins and biochemical recurrence: results from the SEARCH databaseJ L Nelles, S J Freedland, J C Presti, et al.
The Journal of Urology|August 19, 2007
Predicting unilateral prostate cancer based on biopsy features: implications for focal ablative therapy--results from the SEARCH databaseCharles D Scales, Joseph C Presti, Christopher J Kane, et al.
BJU International|November 22, 2008
Do nomograms predict aggressive recurrence after radical prostatectomy more accurately than biochemical recurrence alone?Florian R Schroeck, William J Aronson, Joseph C Presti, et al.
Pageof 58